Acceleron Pharma Inc (NASDAQ:XLRN)

Delayed Data
As of 4:00pm ET
 -2.28 / -2.10%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Acceleron Pharma Inc have a median target of 133.00, with a high estimate of 155.00 and a low estimate of 100.00. The median estimate represents a +25.27% increase from the last price of 106.17.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Acceleron Pharma Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -79.81%
Growthannually -5.32%


Growthquarterly -33.92%
Growthannually 34.64%
Key to the earnings and sales forecast charts.